Logo image of FRBN

FORBION EUROPEAN ACQUISITI-A (FRBN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:FRBN - KYG3619H1020 - Common Stock

21.695 USD
-0.87 (-3.88%)
Last: 10/31/2023, 8:11:12 PM
20.14 USD
-1.55 (-7.17%)
After Hours: 10/31/2023, 8:11:12 PM
Fundamental Rating

1

FRBN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. Both the profitability and financial health of FRBN have multiple concerns. FRBN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

FRBN had negative earnings in the past year.
FRBN had a negative operating cash flow in the past year.
FRBN Yearly Net Income VS EBIT VS OCF VS FCFFRBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA -1.74%
ROE -1.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FRBN Yearly ROA, ROE, ROICFRBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 -0.2 -0.4 -0.6 -0.8 -1

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FRBN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FRBN Yearly Profit, Operating, Gross MarginsFRBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, FRBN has about the same amount of shares outstanding.
There is no outstanding debt for FRBN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FRBN Yearly Shares OutstandingFRBN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M
FRBN Yearly Total Debt VS Total AssetsFRBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

FRBN has an Altman-Z score of 17.18. This indicates that FRBN is financially healthy and has little risk of bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that FRBN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 17.18
ROIC/WACCN/A
WACCN/A
FRBN Yearly LT Debt VS Equity VS FCFFRBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

FRBN has a Current Ratio of 0.04. This is a bad value and indicates that FRBN is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.04 indicates that FRBN may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
FRBN Yearly Current Assets VS Current LiabilitesFRBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M

0

3. Growth

3.1 Past

The earnings per share for FRBN have decreased strongly by -166.89% in the last year.
EPS 1Y (TTM)-166.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-948.87%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

FRBN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FRBN Price Earnings VS Forward Price EarningsFRBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FRBN Per share dataFRBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FRBN!.
Industry RankSector Rank
Dividend Yield N/A

FORBION EUROPEAN ACQUISITI-A

NASDAQ:FRBN (10/31/2023, 8:11:12 PM)

After market: 20.14 -1.55 (-7.17%)

21.695

-0.87 (-3.88%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap343.00M
Revenue(TTM)N/A
Net Income(TTM)-2.37M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.76
P/tB 2.76
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0
BVpS7.87
TBVpS7.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.74%
ROE -1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 17.18
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-166.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-948.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-573.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.16%
OCF growth 3YN/A
OCF growth 5YN/A

FORBION EUROPEAN ACQUISITI-A / FRBN FAQ

What is the ChartMill fundamental rating of FORBION EUROPEAN ACQUISITI-A (FRBN) stock?

ChartMill assigns a fundamental rating of 1 / 10 to FRBN.


Can you provide the valuation status for FORBION EUROPEAN ACQUISITI-A?

ChartMill assigns a valuation rating of 0 / 10 to FORBION EUROPEAN ACQUISITI-A (FRBN). This can be considered as Overvalued.


What is the profitability of FRBN stock?

FORBION EUROPEAN ACQUISITI-A (FRBN) has a profitability rating of 0 / 10.